neonatal News
-
Leading The Way in Neonatal Therapies
Buffalo Business First speaks to ONY Biotech about the company’s continued strides toward creating innovative therapies to improve outcomes for premature babies and their families. With a clinical trial for an aerosolized surfactant therapy recently completed and other product developments underway, ONY Biotech is poised to change the landscape of neonatal respiratory therapy as it’s ...
By ONY Biotech
-
In The ISIF`19 / 4. Istanbul International Invention Fair, Excellence And Creative Effort Awards Were Given.
Tende, who was invited to ISIF'19 / 4th Istanbul International Invention Fair within the framework of Teknofest 2019, took its place in the festival with the invention of Babyblue 360 Tunnel Type Intensive LED Phototherapy Device for Neonates. The patents participating in the competition were evaluated for their “Excellence and creative effort to invent”. Approximately 350 patents ...
-
Incidence of traumatic lumbar punctures in neonates and infants
Our whitepaper takes a closer look at the lumbar puncture, the IQ-Tip system’s first indication, and presents the results that Injeq has obtained with the system. We discuss the various advantages that the system provides compared to a conventional spinal needle. You can download the white paper here: Clinical applications for the IQ-Tip system and their potential benefits ...
By Injeq Oy
-
Ony Cares For Kids Too
On May 9th, 2019, local radio stations Kiss 98.5 and WBEN hosted the annual Kiss Cares for Kids/ WBEN Radiothon to benefit Oishei Children’s Hospital. The entire radiothon raised over $208,000, surpassing the original $173,000 goal that would enable the hospital to purchase a new ENT Tower. Oishei Children’s Hospital provides state-of-the-art medical care to members of the Buffalo ...
By ONY Biotech
-
Neonatal Incubator Developed By MOm And Eg Technology Achieves First Clinical Use In The UK
Created by mOm Founder & CEO, James Roberts, and developed by mOm & the engineering team at eg technology, this innovative, lightweight incubator helped to sustain a premature baby’s life at St Peter’s Hospital, Chertsey. The mOm incubator was originally conceived to save the lives of premature babies in challenging, low/middle-income settings; as well as provide more options ...
-
`Scivita Medical Navigates Medical Innovation` Scivita 4K Ultra-High Definition Laparoscopy in Pediatric Surgery Seminar
On October 18. 2020. the online meeting of "Scivita Medical Navigates Medical Innovation' Scivita 4K Medical Ultra-high-definition Laparoscopy in Pediatric Surgery Seminar sponsored by Pediatric Surgery Branch of Guangdong Medical Association and undertook by Guangzhou Women and Children' s Medical Center was successfully held. The conference focused on how to effectively use endoscopy to ...
-
Ony Biotech Prepares For The Future
Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started working at the Children’s Hospital of Buffalo. This month, it becomes official, as Dr. Cummings joins the ONY Biotech team as Chief Medical Officer, and the founder of the company and former Chief Medical Officer, Dr. Edmund Egan, steps into the role of Chief Scientific Officer. ...
By ONY Biotech
-
Aerogen supports global vaccine equity and neonatal health with UNICEF
UNICEF Ireland welcomes two-year partnership with Galway-based Aerogen UNICEF and Aerogen have announced a two-year partnership in support of UNICEF’s work in the areas of global vaccine equity and the health of newborns. In 2021, Aerogen has committed €50,000 to go towards funding UNICEF’s delivery of 2 billion COVID-19 vaccines to the most vulnerable families, health workers ...
By Aerogen
-
Isabel Healthcare’s AI Symptom Checker / Virtual Triage Platform Now Available in Multiple Languages
Isabel Healthcare announced to today that the AI Symptom Checker / Virtual Triage platform is now available in multiple languages. The initial release of the multi-language enhancement added Spanish, Dutch, German and Arabic. Isabel has a pipeline of additional languages that it will be announcing in the months ahead. The multilanguage feature brings Isabel’s unique AI and approach to ...
-
New mechanism of Elafin to prevent lung injury in mechanically ventilated newborns
tiakis BIOTECH AG today announced the publication of research results by Alcazar et al. from Stanford University on a new mechanism by which Elafin rescues lung cell survival in the lung of newborn mice subjected to mechanical ventilation. Neonatal chronic lung disease or bronchopulmonary dysplasia develops in preterm infants whose lungs are incompletely developed and therefore require ...
-
Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions, announced today that the Food and Drug Administration (FDA) has granted it's lead compound, ENA-001, rare pediatric disease designation for the treatment of Apnea of Prematurity. Enalare is planning to develop this unique agnostic ...
-
Isabel Healthcare partners with Riverwood Healthcare to offer online symptom checker
Isabel Healthcare and Riverwood Healthcare have partnered to integrate Isabel’s AI symptom checker / self-triage platform into the Riverwood website to enhance care access and patient engagement. The symptom checker has been customized for Riverwood with integration of live chat and care option selection links and other pertinent content to help patients navigate to Riverwood care services ...
-
Isabel’s AI Engine to be Embedded in iCliniq`s Virtual Care Platform
Isabel Healthcare announced an agreement with iCliniq to integrate Isabel’s AI symptom checker / self-triage engine into the iCliniq’s Platform. iCliniq will utilize Isabel’s comprehensive API to embed the virtual triage engine into the consumer-facing workflows of their platform providing accurate and efficient self-triage engagement with users. As a global player in the ...
-
Two New Uscom Devices for China
Uscom has completed the development of two new specialised cardiovascular monitors, the “USCOM O2” and the “USCOM Basic”. The development of these two new monitors creates for Uscom a three-tier range of Uscom haemodynamic monitors for sale into China. Uscom is required to obtain regulatory approval of the China National Medical Products Administration (NMPA) for the two ...
By Uscom Ltd
-
New study reports activated B. infantis EVC001 feeding substantially reduces enteric inflammation, diaper rash and antibiotic use in preterm infants
Researchers publishing in the peer-review journal Frontiers in Pediatrics report that pre-term infants fed Bifidobacterium longum subsp. infantis (activated B. infantis EVC001) experienced significantly lower level of intestinal inflammation, 62% less diaper rash, and required 62% fewer antibiotics– all of which are critical health indicators in neonatal care. The study, Impact of ...
-
Study Results Are In On A Potential Non-Invasive Treatment For Rds
For little lungs everywhere, the families that love them, and the neonatologists who care for them, there’s news coming out of ONY Biotech, a family-focused neonatology pharmaceutical company. Today, ONY Biotech announced the results of a clinical trial on its aerosolized surfactant for newborns with respiratory distress syndrome (RDS), a disorder caused by lack of surfactant that can ...
By ONY Biotech
-
Virometix Announces Completion of Initial Vaccination of the First Dose Cohort in Phase 1 Study with V-306
Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, announced today the completion of initial vaccination of the first dose cohort in the Phase 1 healthy volunteer study of V-306, its candidate vaccine for prophylaxis of RSV (Respiratory Syncytial Virus) ...
By Virometix AG
-
Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)
ENA-001, a New Chemical Entity (NCE) with a novel mechanism of action as an agnostic respiratory stimulant, has previously been granted Rare Pediatric Disease designation for the Treatment of AoP by the FDA, with eligibility for a priority review voucher (PRV). The compound is also being developed by Enalare for the treatment of post-operative respiratory depression and community drug overdose. ...
-
Alfa Chemistry Offers High-Quality Dexmedetomidine Hydrochloride Meeting CP & EP Standards
Having established close cooperative relations with many pharmaceutical companies, universities, and research institutions, Alfa Chemistry decided to enlarge its active pharmaceutical ingredient (API) supply continuously in the hope of providing a more diversified product portfolio for customers. Fairly recently, the company announced the launch of dexmedetomidine hydrochloride, another API ...
-
Texas Children’s Pavilion for Women Teams up With PeriGen to Bring PeriWatch Vigilance® to Malawi
Texas Children’s Pavilion for Women® announced today the launch of the PeriWatch Vigilance® program in Lilongwe, Malawi (in southern Africa), in partnership with PeriGen Advanced Perinatal Software, a provider of innovative software solutions for over 20 years with a mission to protect mothers and babies everywhere. In a public-private partnership with the Texas Children’s ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you